Lyka Labs Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2013
2014
2016
2017
2018
2019
Sales/Revenue
1,187
872
1,276
1,065
598
708
Cost of Goods Sold (COGS) incl. D&A
963
746
971
837
576
612
Gross Income
224
125
305
228
22
95
SG&A Expense
203
172
213
202
186
187
EBIT
16
56
-
43
165
92
Unusual Expense
18
200
68
29
22
-
Non Operating Income/Expense
175
67
145
89
21
10
Interest Expense
191
216
152
173
80
72
Pretax Income
4
7
39
67
200
154
Income Tax
-
10
2
10
10
91
Consolidated Net Income
4
3
41
57
190
64
Net Income
7
13
37
47
172
56
Net Income After Extraordinaries
7
13
37
47
172
56
Net Income Available to Common
14
14
36
48
172
56
EPS (Basic)
0.67
0.66
1.65
2.17
6.71
1.79
Basic Shares Outstanding
22
22
22
22
-
-
EPS (Diluted)
0.67
0.66
1.65
2.17
-
-
Diluted Shares Outstanding
22
22
22
22
-
-
EBITDA
133
14
199
133
52
19
Other Operating Expense
6
10
14
16
-
-
Non-Operating Interest Income
23
13
9
4
-
-
Minority Interest Expense
11
10
4
10
18
7
Preferred Dividends
7
1
1
1
-
-

About Lyka Labs

View Profile
Address
Ground Floor, Spencer Building
Mumbai Maharashtra 400036
India
Employees -
Website http://www.lykalabs.com
Updated 07/08/2019
Lyka Labs Ltd. is a healthcare company, which engages in the manufacture of pharmaceutical formulations and active pharmaceutical ingredients. Its products include lyophilized injections, topical formulations of cream, ointment, foams, gels, and lotions. The company was founded on December 29, 1976 and is headquartered in Mumbai, India.